Leukemia inhibitory factor: a potential biomarker and therapeutic target in pancreatic cancer

• Autorzy: Wrona E. , Potemski P. , Sclafani F. , Borowiec M.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

pancreatic ductal adenocarcinoma; pancreatic cancer; biomarker; leukemia inhibitory factor; monoclonal antibody; epithelial-mesenchymal transition; therapeutic target; cell differentiation; patient

• Wydawca: -
• Czasopismo: Archivum Immunologiae et Therapiae Experimentalis
• Rocznik: 2021
• Tom: 69
• Numer: 1
• Opis fizyczny: Article 2 [8p.], fig.,ref.

Twórcy

autor

Wrona E.

• Department of Clinical and Laboratory Genetics, Medical University of Lodz, Lodz, Poland
• Department of Chemotherapy, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland

autor

Potemski P.

• Department of Chemotherapy, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland

autor

Sclafani F.

• Gastrointestinal Unit, Department of Medical Oncology, Institut Jules Bordet – Universite Libre de Bruxelles (ULB), Brussels, Belgium

autor

Borowiec M.

• Department of Clinical and Laboratory Genetics, Medical University of Lodz, Lodz, Poland

Identyfikatory

DOI

10.1007/s00005-021-00605-w